Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020901 220008842 1.69 null Palliative (P) 2017-03-05 2017-06-08 Cytarabine intrathecal 02 N 220033249 CYTARABINE INTRATHECAL
220020902 220008845 1.71 71.6 Adjuvant (A) 2016-04-24 2016-07-15 CARBOPLATIN + PACLITAXEL N N 220033250 CARBOPLATIN + PACLITAXEL
220020903 220008858 1.69 83.7 Curative (C) 2017-08-07 2017-08-17 GEMTUZUMAB OZOGAMICIN N N 220033294 CLOFARABINE + CYTARABINE
220020904 220008866 1.6 57 Curative (C) null 2017-03-01 Carboplatin + Etoposide iv&po N N 220033348 CARBOPLATIN + ETOPOSIDE
220020905 220008868 1.83 69 Curative (C) 2014-10-10 2015-02-15 GEMTUZUMAB OZOGAMICIN null N 220033375 METHOTREXATE
220020906 220014752 1.5 57 null 2016-04-21 2016-10-09 PACLITAXEL N N 220033397 PACLITAXEL
220020907 220008874 1.6 56 Curative (C) 2015-11-28 2015-12-04 Cytarabine intrathecal N N 220033438 CYTARABINE INTRATHECAL
220020908 220008876 1.44 93.8 null 2015-01-15 2015-01-15 ALEMTUZUMAB + BUSULFAN + FLUDARABINE N N 220033442 UKALL2014
220020909 220008882 1.78 106 Curative (C) 2019-01-16 2019-01-17 Mitox + Tretinoin Spanish Course 3 null null 220033449 MITOXANTRONE
220020910 220008886 1.68 59 Curative (C) 2018-12-10 2019-04-29 Irinotecan + Modified De Gramont N N 220033473 UKALL2014
220020911 220008891 1.74 51 Palliative (P) 2016-06-06 2016-08-17 Alemtuzumab cond (RI ALLO CAMP100) N N 220033475 ALEMTUZUMAB
220020912 220008894 null 71.4 Curative (C) 2017-02-02 2017-02-02 Cytarabine intrathecal null null 220033484 CYTARABINE INTRATHECAL
220020913 220008898 1.5 28.3 Curative (C) 2016-06-17 2016-06-26 Cisplatin + Gemcitabine (D 1 & 8) 2 N 220033508 PONATINIB
220020914 220008907 1.69 58.1 Palliative (P) 2017-12-27 2017-12-27 Oxaliplatin + Modified de Gramont null null 220033515 PONATINIB
220020915 220021913 1.77 43.85 Palliative (P) 2016-11-19 2016-11-29 Dacarbazine N null 220033520 EC
220020916 220014770 null 45 Palliative (P) 2016-05-27 2016-05-27 Alemtuzumab+Busulfan+CyclophosphMUD N null 220033551 FLUDARABINE
220020917 220014772 null null Curative (C) 2018-10-30 2018-10-30 Alemtuzumab + Cyclophos TBI Allo null null 220033567 CETUXIMAB
220020918 220014774 1.59 64.75 Curative (C) 2016-03-02 2016-03-03 GCLAC null N 220033571 BUSULPHAN + FLUDARABINE
220020919 220014778 1.78 71.6 Disease modification (D) 2016-12-10 2017-01-19 Kadcyla N null 220033680 CYTARABINE IT + METHOTREXATE
220020920 220018081 null 110.2 Palliative (P) 2017-01-31 2017-03-06 TIP N null 220033681 MACE
220020921 220014781 null null Curative (C) 2016-02-03 2016-03-30 Alemtuzumab + Cyclophos TBI Allo 99 null 220033699 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220020922 220014781 2 68.45 Curative (C) 2016-03-03 2016-03-05 LIPOSOMAL CYTARABINE N N 220033699 FIGARO TRIAL
220020923 220021583 1.77 79.8 Palliative (P) 2015-01-14 2015-01-14 TEMOZOLOMIDE N N 220033717 THALIDOMIDE
220020924 220008959 1.75 69 Curative (C) 2017-08-05 2017-10-12 Folfirinox N N 220033807 DABRAFENIB
220020925 220008968 1.7 null Curative (C) 2018-07-22 2018-07-30 Capecitabine + Oxaliplatin 21day 2 N 220033808 GCLAC
220020926 220008973 null null Curative (C) null 2014-01-08 Sorafenib N N 220033816 BUSULFAN + CYCLOPHOSPHAMIDE
220020927 220020992 1.65 89 Curative (C) null 2016-04-11 GCLAC N N 220033832 CISPLATIN
220020928 220009011 1.73 89.9 Curative (C) 2016-07-31 2016-10-10 CYTARABINE + FLUDARABINE N N 220033965 MERCAPTOPURINE
220020929 220009021 null 67.3 Not known (9) 2014-10-29 2014-10-29 MITOXANTRONE + TRETINOIN 01 N 220033988 INTERFERON
220020930 220018094 1.67 100 Palliative (P) 2016-05-29 2018-08-25 CISPLATIN + FLUOROURACIL N N 220033997 PACKER INDUCTION VINCRISTINE + RT
220020931 220009028 1.72 71.8 Curative (C) 2017-07-16 2017-12-26 Capecitabine 02 N 220034002 MITOXANTRONE + TRETINOIN
220020932 220009032 1.63 null Disease modification (D) 2016-10-29 2016-11-30 Cytarabine+Methotrexate Intrathecal N N 220034022 CETUXIMAB
220020933 220019934 null 58.5 Curative (C) 2017-11-13 2017-11-13 Cisplatin + Etoposide po&iv 3 day 99 2 220034035 FIGARO TRIAL
220020934 220009046 null null Disease modification (D) 2015-02-03 2015-02-04 MACE N null 220034070 BUSULFAN + FLUDARABINE
220020935 220009049 1.78 102.4 Curative (C) 2015-04-25 2015-05-20 Sorafenib Y null 220034079 INTERFERON
220020936 220009052 null 76.3 Curative (C) 2014-10-01 2014-10-01 QUASAR 2 TRIAL 01 N 220034081 ARSENIC TRIOXIDE
220020937 220009061 0 87 Curative (C) null 2017-01-05 Capecitabine (21 day) + Irinotecan N N 220034115 MIDAC
220020938 220009067 null 116.3 Curative (C) null 2014-11-08 Cytarabine+Methotrexate Intrathecal N null 220034117 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN
220020939 220009082 null null Curative (C) 2018-09-21 2018-10-04 Cytarabine+Methotrexate Intrathecal N null 220034164 MACE
220020940 220009086 null 48.8 Curative (C) null 2016-10-04 LENALIDOMIDE 2 N 220034194 BUSULFAN + CYCLOPHOSPHAMIDE
220020941 220009091 null 62 Disease modification (D) 2016-11-08 2017-02-02 DABRAFENIB + TRAMETINIB 02 N 220034218 LENALIDOMIDE
220020943 220009104 -1 29 Curative (C) 2017-05-19 2017-08-08 CYTARABINE + FLUDARABINE + IDARUBICIN null null 220034277 CAPECITABINE
220020944 220019941 1.71 83.3 Curative (C) 2015-08-18 2016-06-12 Busulfan + Cyclophos Conditioning N N 220034302 CARFILZOMIB
220020945 220014863 1.69 79 Curative (C) 2014-08-25 2014-08-25 MidAC N N 220034334 FIGARO TRIAL
220020946 220009119 1.73 16 Palliative (P) 2015-02-02 2015-10-16 AML LI-1 Trial 01 N 220034346 OSIMERTINIB
220020947 220009125 1.63 null null 2015-06-30 2015-10-07 CYCLOPHOSPHAMIDE + THALIDOMIDE N N 220034356 CARBOPLATIN
220020948 220014869 1.69 104.499 Adjuvant (A) null 2018-02-09 FIGARO TRIAL 01 null 220034364 TRASTUZUMAB EMTANSINE
220020949 220009133 1.69 68 Curative (C) 2017-08-05 2017-08-05 BUSULFAN + CYCLOPHOSPHAMIDE + FLUDARABINE N N 220034423 THALIDOMIDE
220020950 220009136 1.74 23.8 Disease modification (D) null 2018-10-12 Cisplatin 7 day 01 N 220034424 FIGARO TRIAL
220020951 220009141 1.75 14.1 Curative (C) 2016-02-06 2016-02-25 VINORELBINE N N 220034425 IPO